Correction to Inspector Appointment Disclosure: Addition of Plaintiffs
Enzychem Lifesciences filed a corrected disclosure on July 23, 2026, modifying the plaintiffs/applicants to Nam OOO and two others regarding the court decision to appoint an inspector received on July 22, 2026.
The correction reaffirms the court's appointment of lawyer Kwon Jongwon as inspector to examine the legality of the extraordinary general meeting scheduled for July 23, 2026, related to a management dispute, with the company bearing the inspector remuneration of 5.5 million won.
Beyond the addition of plaintiffs, the substance of the inspector appointment remains unchanged, so management uncertainty persists but the correction has limited direct impact on shareholder value.
[AI Summary]This amendment is a clerical correction with no financial shock, confirming procedural progress with the inspector appointment. While short-term stock volatility due to the management dispute remains possible, the unchanged terms and schedule warrant a neutral stance.
KOSDAQ Filing Information
[Correction of Description] Judgment/Decision on Lawsuit, etc. (Management Rights Dispute Lawsuit) (Appointment of Inspector)